Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for June 2008
June 2, 2008
- Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
- Antitrust: EU Commission Opens Formal Proceedings Against Sanofi-Aventis for Possible Procedural Infringement
- Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa in Women with Early-stage Breast Cancer
- MediGene AG (DE) - MediGene Focuses its Strategy on Oncology and Immunology
June 3, 2008
- Mergent, Inc. Announces Changes to the HealthShares Metabolic-Endocrine Disorders Index
- New Pfizer Data Presented on CP-751,871 across Non-Small Cell Lung Cancer and Ewing's Sarcoma
- Pfizer Reviews Progress of Oncology Pipeline and New Commercial Business Unit Structure with Analysts
- Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim
- AMSA PharmFree Scorecard Grades U.S. Medical Schools on Conflict-of-Interest Policies; Only 7 Receive an 'A'
- New Improved Dosing Approved for Pennsaid
- GeneGo Extends Agreement With Merck & Co., Inc.
- Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
- Roche NimbleGen and BioDiscovery Form Strategic Alliance to Enhance CGH Microarrays, Software and Services
- Altus Pharmaceuticals Reports ALTU-237 Phase 1 Clinical Trial Results
June 4, 2008
- Protez Pharmaceuticals to Be Acquired by Novartis
- Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
- Low HDL Cholesterol from Gene Variation Not Associated with Increased Risk of Ischemic Heart Disease
- Novartis Gains Rights to Promising Hospital Antibiotic in Clinical Development Through Full Acquisition of Protez Pharmaceuticals
- Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
- Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
June 5, 2008
- Ipsen to Acquire Tercica
- Calif. AG Brown To Launch Online Technology To Fight Prescription Drug Abuse
- FDA Broadens US Indication for Once-Yearly Reclast as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
June 6, 2008
- GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
- US FDA Grants Pediatric Exclusivity for UCB's Keppra
- European Medicines Agency Recommends Measures to Manage Contamination of Heparin-containing Medicines
- Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
- FDA Announces New Labeling Changes for Regranex
June 9, 2008
- QLT Announces Agreement to Sell Aczone to Allergan for Approximately US$150 Million
- CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
- New Data Released at Major Diabetes Meeting on Initial Combination Therapy with Januvia (sitagliptin), Merck's Diabetes Medicine, and Metformin through Two Years of Treatment
- Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on Avandia
- Sucampo Pharma Europe Submits Marketing Authorization Application in Switzerland
- Cytrx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
- Noven Provides Update on Daytrana Methylphenidate Transdermal System
- Canon Communications LLC Announces the Redesign of Its Medical Device Link Portal
- PharmaLinkFHI Acquires UK-Based Matrix Contract Research Ltd.
June 10, 2008
- Administration Proposes Additional Funding for FDA to Improve Food and Medical Product Safety
- Merck Strengthens Its Prescription Medicines Portfolio in Latin America
- ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets
- Valeant Pharmaceuticals Divests Argentina
- Targacept and AstraZeneca Initiate Clinical Trial of AZD3480 in Adult ADHD
- RiskMetrics and Glass Lewis Endorse All Four Biogen Idec Director Nominees
- 11th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals:
- AVI BioPharma Provides Update on New Business Plan: Increased Pipeline Focus, Skill Base and Strategy, Discontinuation of AVI–5126 Trial in CABG
June 11, 2008
- Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
- LAB Research receives revised demand letter from Akela Pharma
- Immunicon Files for Strategic Restructuring
- Global Market for Pharmaceuticals Worth Over $1 Trillion by 2013
- Innovation is Rapidly Globalizing: India and China are Becoming Centers of Pharmaceutical R&D says Kauffman Foundation Study
June 12, 2008
- Encorium Group, Inc. Announces Signing of Letter of Intent to Acquire Prologue Research International, Inc.
- Encorium Group, Inc. Announces Signing of Letter of Intent to Combine with Linkcon; Expected Expansion Will Create Global CRO
- Genentech Settles Dispute Related to Cabilly Patent
- Jazz Pharmaceuticals Announces Development Timeline Updates
- Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster
- FDA, European Medicines Agency to Consider Additional Test Results When Assessing New Drug Safety
June 13, 2008
- PAREXEL Reaches Agreement to Acquire ClinPhone
- FDA, European Medicines Agency to Consider Additional Test Results When Assessing New Drug Safety
- Sen. Grassley Seeks FDA Scrutiny of Paxil and Suicide Risk
June 16, 2008
- Drug Makers Differ Strongly in Policies for Low-income Countries
- Novartis Vaccines and Diagnostics S.r.l. Withdraws Its Marketing Authorisation Application for the Pre-pandemic Vaccine Aflunov
- Information for Healthcare Professionals: Antipsychotics
- Ore Pharmaceuticals Focuses Resources on Development of Repositioned Compounds
- Biovail Recommends Shareholders Vote to Move Forward from the Melnyk Lost Years
June 17, 2008
- FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs
- IMS Health Reports Global Biotech Sales Grew 12.5 Percent in 2007, Exceeding $75 Billion
- Boehringer Ingelheim to Acquire Actimis Pharmaceuticals
- Reps. Dingell, Stupak Welcome PhRMA Invitation to Discuss DTC Regulations
- Decision Resources, Inc. Acquires Manhattan Research
- Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set Of Services
June 18, 2008
- Statement Regarding Official Publication of Voluntary Takeover Offer by Anthiarose Limited
- Sanofi-aventis Intends to Make a Competing Bid of CzK 1,050 in Cash Per Share for Zentiva
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
- Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
- FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
- Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Kosan Biosciences Incorporated
- EMEA Recommends Information on Lung Cancer Cases to Be Included in Exubera Product Information
- Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion
- Majority of Americans Support Legislative Action to Disclose Pharmaceutical Company Gifts to Physicians
- Johnson & Johnson Nordic AB Acquires Amic
June 19, 2008
June 20, 2008
- Intas Biopharmaceuticals Ltd. Acquires US-based BPD Inc.
- Canada's Research-Based Pharmaceutical Companies Invested Over a Billion Dollars in Research and Development (R&D) in 2007 But Opportunities Exist for Further Growth, Says Rx&D
- YM BioSciences Announces FDA Lifts Clinical Hold on Aerolef and Clearance of a Phase II Clinical Trial
- Merck Provides Update on U.S. Regulatory Status of MK-0524A (ER niacin/laropiprant) and MK-0524B (ER niacin/laropiprant/simvastatin)
- Should Doctors Be 'Selling' Drugs for the Pharmaceutical Industry?
June 23, 2008
- GTC Biotherapeutics Enters Into $257 Million Agreement with Ovation Pharmaceuticals to Develop and Market ATryn in the U.S.
- FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane
- Barrier Therapeutics to Merge Into Stiefel Laboratories
June 24, 2008
- Center for Public Integrity: Drug Industry Spent Record Amount Lobbying in '07 Over a Billion Dollars Spent in the Last 10 Years
- Federal Action Needed to Fill Antibiotic Pipeline, Says the Alliance for the Prudent Use of Antibiotics
June 25, 2008
- Use of Drug-Releasing Stents Associated With Decrease in Repeat Procedures to Unblock Coronary Arteries
- Savings Help the Medicine Go Down
- New Report: The Truth About Drug Innovation
- Concerned Shareholders of Biovail Seek Court Order Declaring Biovail AGM Illegally Convened;
- Center for Communication Compliance Launches First Regulatory Resource, Training and Certification Portal for Healthcare Communicators
June 26, 2008
- CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years
- Sen. Grassley Calls on Congress and NIH Leaders to Identify Conflicts of Interest in Taxpayer Sponsored Medical Research
- Further Steps in Generation Change at Boehringer Ingelheim
- AstraZeneca Announces Senior Management Changes at Biologics Business Unit, MedImmune
June 27, 2008
- Bristol-Myers Squibb Completes Acquisition of Kosan Biosciences Incorporated
- Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
- FDA Approves Concerta (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
June 30, 2008
- GlaxoSmithKline Responds to FDA on Cervarix and Plans to Submit Final Study Data for Approval
- Suspension of Shares for Trading on the Official List, Entry Into Voluntary Administration
- ACCME Receives Request for Information from U.S. Senate Special Committee on Aging
- A New Citeline Analysis Provides Valuable Clues to Health of Drug Companies
- Novexel Discontinues Development of NXL 101
- FDA MedWatch- CellCept (mycophenolate mofetil)-Reports Of Progressive Multifocal Leukoencephalopathy In Patients Treated With CellCept
